MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Elanco Animal Health Incorporated Cost of Revenue 2011-2026 | ELAN
Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.What is included in the cost of revenue
| Cost Category | Examples |
|---|---|
| Production Costs | Materials, wages of production staff, depreciation of equipment |
| Service and Support | Customer service, user support, technical assistance |
| Delivery and Logistics | Packaging, delivery of goods to customers |
| Hosting and Infrastructure | Servers, cloud platforms (especially for IT and SaaS companies) |
| Content and Licenses | License purchases, production royalties (e.g., in streaming services) |
Importance of the Metric
- Helps to understand how costly the revenue-generating process is.
- A high cost of revenue may indicate:
Poor cost control
Low operational efficiency - A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.
Annual Cost of Revenue Elanco Animal Health Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.12 B | 2 B | 1.93 B | 1.91 B | 2.13 B | 1.67 B | 1.47 B | 1.57 B | 1.49 B | 1.41 B | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.13 B | 1.41 B | 1.77 B |
Quarterly Cost of Revenue Elanco Animal Health Incorporated
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 530 M | 528 M | 509 M | - | 492 M | 495 M | 515 M | - | 487 M | 434 M | 494 M | - | 472 M | 484 M | 509 M | - | 502 M | 551 M | 569 M | 596 M | 442 M | 296 M | 333 M | 410 M | 360 M | 356 M | 344 M | 412 M | 370 M | 432 M | 360 M | 405 M | 376 M | 374 M | 339 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 596 M | 296 M | 444 M |
Cost of Revenue of other stocks in the Care facilities industry
| Issuer | Cost of Revenue | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
376 M | - | 10.96 % | $ 46.2 M |  China |
 |
The Ensign Group
ENSG
|
4.02 B | $ 199.21 | 0.1 % | $ 11.4 B |  USA |
 |
Healthcare Services Group
HCSG
|
1.6 B | $ 19.29 | -1.05 % | $ 1.4 B | USA |
 |
Avalon GloboCare Corp.
AVCO
|
1.1 M | - | 26.45 % | $ 70.6 M | USA |
 |
Amedisys
AMED
|
1.33 B | - | 0.01 % | $ 3.3 B | USA |
 |
Apollo Medical Holdings
AMEH
|
1.17 B | - | -2.11 % | $ 1.84 B | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
12.5 B | $ 23.41 | -0.93 % | $ 7.05 B |  Germany |
 |
Option Care Health
OPCH
|
4.56 B | $ 28.57 | -1.5 % | $ 4.63 B | USA |
 |
Chemed Corporation
CHE
|
1.58 B | $ 383.44 | -0.62 % | $ 5.76 B | USA |
 |
Hanger
HNGR
|
398 M | - | - | $ 732 M | USA |
 |
IMAC Holdings
IMAC
|
305 K | - | -1.77 % | $ 25.4 M | USA |
 |
Surgery Partners
SGRY
|
971 M | $ 12.84 | -0.54 % | $ 1.63 B | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
463 M | $ 3.93 | 1.81 % | $ 515 M | China |
|
Sanara MedTech
SMTI
|
7.52 M | $ 16.84 | 1.88 % | $ 145 M | USA |
 |
Tenet Healthcare Corporation
THC
|
8.7 B | $ 189.98 | -2.7 % | $ 17.1 B | USA |
|
Novo Integrated Sciences
NVOS
|
7.55 M | - | -13.87 % | $ 1.52 M | USA |
 |
HCA Healthcare
HCA
|
32.9 B | $ 489.87 | -1.13 % | $ 116 B | USA |
 |
Universal Health Services
UHS
|
8.08 B | $ 179.24 | -0.85 % | $ 11.4 B | USA |
 |
AMN Healthcare Services
AMN
|
2.54 B | $ 18.08 | 1.18 % | $ 708 M | USA |
 |
LHC Group
LHCG
|
1.4 B | - | - | $ 5.27 B | USA |
 |
American Shared Hospital Services
AMS
|
23 M | $ 1.33 | -1.48 % | $ 8.8 M | USA |
 |
National HealthCare Corporation
NHC
|
921 M | $ 168.63 | -1.3 % | $ 2.61 B | USA |
 |
U.S. Physical Therapy
USPH
|
462 M | $ 76.28 | -0.26 % | $ 1.16 B | USA |
 |
Encompass Health Corporation
EHC
|
3.12 B | $ 107.03 | -0.21 % | $ 10.8 B | USA |
 |
MEDNAX
MD
|
1.54 B | $ 21.43 | -0.09 % | $ 1.8 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
896 M | $ 58.67 | 1.35 % | $ 2.38 B | USA |
 |
The Pennant Group
PNTG
|
769 M | $ 30.79 | 0.34 % | $ 1.06 B | USA |
 |
ModivCare
MODV
|
2.37 B | - | -25.23 % | $ 6.12 M | USA |
 |
Select Medical Holdings Corporation
SEM
|
4.82 B | $ 16.38 | 0.06 % | $ 2.01 B | USA |
 |
Acadia Healthcare Company
ACHC
|
1.69 B | $ 25.98 | 0.08 % | $ 2.38 B | USA |
 |
SunLink Health Systems
SSY
|
18.3 M | - | 17.98 % | $ 7.81 M | USA |
 |
Oak Street Health
OSH
|
438 M | - | 0.03 % | $ 9.53 B | USA |
 |
Community Health Systems
CYH
|
1.86 B | $ 3.08 | -2.22 % | $ 411 M | USA |
 |
The Joint Corp.
JYNT
|
9.17 M | $ 8.74 | 0.17 % | $ 127 M | USA |
 |
Ontrak
OTRK
|
4.02 M | - | -11.98 % | $ 1.53 M | USA |
 |
Addus HomeCare Corporation
ADUS
|
961 M | $ 92.31 | 0.1 % | $ 1.67 B | USA |
 |
Regional Health Properties
RHE
|
6.98 M | - | - | $ 5.2 M | USA |
 |
Tivity Health
TVTY
|
278 M | - | 0.09 % | $ 1.6 B | USA |